SCHEMBL8345893

SCHEMBL8345893

Fc1ccccc1-c1nccc(Nc2ccncn2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 10/20 0.48
CYP3A4 P08684 10/20 0.48
CYP2D6 P10635 8/20 0.48
CYP2C19 P33261 8/20 0.48
ALDH1A1 P00352 3/20 0.48
MPL P40238 5/20 0.47
TSHR P16473 4/20 0.47
USP2 O75604 2/20 0.47
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
BUB1 O43683 1/20 0.39
AURKA O14965 1/20 0.39
GSK3A P49840 1/20 0.38
CDK9 P50750 1/20 0.38
CDK5 Q00535 1/20 0.38
TAOK1 Q7L7X3 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
KDR P35968 1/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8348223 0.84 CYP1A2 (0.59) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL14262943 0.77 TGFBR1 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL27998656 0.73 MAPK10 (0.56) MPLKMT2AMEN1AURKAKDR
SCHEMBL8344338 0.73 CYP1A2 (0.53) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL4630887 0.72 GSK3A (0.53) CYP1A2CYP3A4CYP2D6CYP2C19GSK3A
SCHEMBL28296096 0.71 NPC1 (0.50) CYP1A2CYP3A4MPLTSHRKMT2A
SCHEMBL12090607 0.70 ACP1 (0.61) CYP1A2CYP3A4MPLGSK3A
Hydrochloric Acid SCHEMBL7857018 0.70 GSK3A (0.51) CYP1A2CYP3A4CYP2D6CYP2C19GSK3A
SCHEMBL8346915 0.69 MPL (0.49) CYP1A2CYP3A4CYP2D6MPLUSP2
SCHEMBL31355479 0.69 KMT2A (0.57) ALDH1A1TSHRKMT2AMEN1GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004024159-A1 INHIBITORS OF TFGβ SCIOS INC. (US) 2004-03-25 WO disclosed